The return of investment of translational research in inflammatory dermatoses.
van de Kerkhof, Peter C M
The return of investment of translational research in inflammatory dermatoses. [electronic resource] - The Journal of dermatological treatment 2008 - 317 p. digital
Publication Type: Editorial
1471-1753
10.1080/09546630802529178 doi
Adalimumab
Anti-Inflammatory Agents--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Dermatitis--drug therapy
Dermatologic Agents--therapeutic use
Diffusion of Innovation
Drug Therapy, Combination
Etanercept
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Infliximab
Psoriasis--drug therapy
Receptors, Tumor Necrosis Factor--therapeutic use
Research Design
Treatment Outcome
The return of investment of translational research in inflammatory dermatoses. [electronic resource] - The Journal of dermatological treatment 2008 - 317 p. digital
Publication Type: Editorial
1471-1753
10.1080/09546630802529178 doi
Adalimumab
Anti-Inflammatory Agents--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Dermatitis--drug therapy
Dermatologic Agents--therapeutic use
Diffusion of Innovation
Drug Therapy, Combination
Etanercept
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Infliximab
Psoriasis--drug therapy
Receptors, Tumor Necrosis Factor--therapeutic use
Research Design
Treatment Outcome